期刊文献+

参芪复方对糖尿病GK大鼠肠道菌群及血糖波动的影响 被引量:11

Effect of Shenqi Compound on Intestinal Microflora and Blood Glucose Fluctuations in Diabetic GK Rats
下载PDF
导出
摘要 目的:探讨参芪复方对糖尿病GK大鼠肠道菌群及血糖波动的影响。方法:建立由高脂饲料喂养的糖尿病大血管病变大鼠模型。实验分4组,Wistar组,模型组,参芪复方组,西药组。于灌胃后每周1次测1日内8∶00,10∶00,14∶00,16∶00,18∶00五次血糖水平,并用血糖稳定性指标(MBG、SDBG、LAGE)量化各组血糖稳定性;检测血清GLP-1水平;运用16SrDNA基因测序分析各组大鼠肠道菌群。结果:参芪复方组可减少大鼠血糖波动,升高血清GLP-1水平,增加拟杆菌门/厚壁菌门比值,升高拟杆菌属、丁酸菌属、Blautia菌属、罗氏菌属的相对丰度。结论:具有养阴益气活血功效的参芪复方可调节肠道菌群,增加产丁酸菌的相对丰度,促进GLP-1分泌,达到调节血糖稳态,防治糖尿病大血管病变的作用。 Objective: To explore the mechanism of Shenqi Compound on intestinal microflora and blood glucose fluctuations in diabetic GK rats. Methods: We established a rat model of diabetic macroangiopathy fed with high-fat-diet. The model rats were randomly divided into Wistar group,model group,Shenqi group,Sitagliptin group( referred to as the Western medicine group),a total of 4 groups. Starting from the gavage administration once a week measured at 8:00,10:00,14:00,16:00,18:00 five-point blood glucose levels. The blood glucose stability was quantified with the indexes of MBG,SDBG and LAGE. We detected GLP-1 level in serum. The intestinal flora of rats was analyzed by16 SrDNA gene sequencing. Results: Shenqi Compound can reduce blood glucose fluctuations in rats,increase serum GLP-1 levels,increase Bacteroides/Firmicutes ratio,raise Bacteroides,Butyricimonas,Blautia and Roseburia relative abundance. Conclusion: Shenqi Compound Recipe which has the function of supplenmenting Qi and Yin and promoting the blood circulation,may achieve the function of regulating blood glucose homeostasis and preventing and treating diabetic macroangiopathy by regulating the intestinal microflora,increaseing the relative abundance of butyrate-producing bacteria,promoting the secretion of GLP-1.
作者 张翕宇 晁俊 王鹤亭 刘晓瑞 王钧东 谢春光 刘桠 ZHANG Xiyu;CHAO Jun;WANG Heting;LIU Xiaorui;WANG Jundong;XIE Chunguang;LIU Ya(Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 610072,Sichuan,China)
出处 《中华中医药学刊》 CAS 北大核心 2019年第8期1855-1858,I0009,共5页 Chinese Archives of Traditional Chinese Medicine
基金 国家自然科学基金项目(81503566)
关键词 糖尿病大血管病变 参芪复方 肠道菌群 血糖波动 GLP-1 diabetic macroangiopathy Shenqi Compound Recipe intestinal microflora blood glucose fluctuations GLP-1
  • 相关文献

参考文献3

二级参考文献40

  • 1喻明,周健,项坤三,陆惠娟,马晓静,陆蔚.动态监测糖耐量正常者血糖水平的漂移变化[J].中华医学杂志,2004,84(21):1788-1790. 被引量:50
  • 2谢海龙,都晓伟,王立娟.中药皂苷类成分防治糖尿病的药理研究进展[J].中医药学报,2006,34(6):45-47. 被引量:7
  • 3Goke B.Islet cell function:alpha and beta cells-partners towards normoglycaemia.Int J Clin Pract Suppl,2008,(159):2-7.
  • 4Kim MH,Lee MK.The incretins and pancreatic beta-cells:use of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide to cure type 2 diabetes Mellitus.Korean Diabetes J,2010,34:2-9.
  • 5Kim W,Egan JM.The role of incretins in glucose homeostasis and diabetes treatment.Pharmacol Rev,2008,60:470-512.
  • 6Neumiller JJ,Wood L,Campbell RK.Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.Pharmacotherapy,2010,30:463-484.
  • 7Deacon CF.Circulation and degradation of GIP and GLP-1.Horm Metab Res,2004,36:761-765.
  • 8Deacon CF,Carr RD,Holst JJ.DPP-4 inhibitor therapy:new directions in the treatment of type 2 diabetes.Front Biosci,2008,13:1780-1794.
  • 9Lankas GR,Leiting B,Roy RS,et al.Dipeptidyl peptidase Ⅳ inhibition for the treatment of type 2 diabetes:potential importance of selectivity over dipeptidyl peptidases 8 and 9.Diabetes,2005,54:2988 -2994.
  • 10Holst JJ,Deacon CF.Inhibition of the activity of dipeptidyl-peptidase Ⅳ as a treatment for type 2 diabetes.Diabetes,1998,47:1663-1670.

共引文献251

同被引文献185

引证文献11

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部